Stokes v. Zhejiang Huahai Pharmaceutical Co., Ltd. et al
| GEORGE STOKES |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD, Prinston Pharmaceutical, Inc., dba Solco Heathcare US, LLC, TEVA PHARMACEUTICAL INDUSTRIES LTD, TEVA PHARMACEUTICALS USA INC, ACTAVIS LLC and HUAHAI U.S. INC. |
| VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION |
| 1:2021cv20419 |
| December 9, 2021 |
| US District Court for the District of New Jersey |
| Sharon A King |
| Robert B Kugler |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. ยง 1391 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on December 9, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 8 Clerk's Notice to Counsel. (dd, ) |
| Filing 7 Certified Copy of Transfer Order and docket received, Case transferred in from District of Florida Northern; Case Number 3:21-cv-02724. Original file certified copy of transfer order and docket sheet received. |
| Judge Robert B. Kugler and Magistrate Judge Sharon A. King added. (dd, ) |
| Case Transferred from Florida Northern 3:21-02724 on 12/9/21 per CTO 48 (dd, ) |
| For all Case Management Orders #click here (dd, ) |
| Filing 6 CERTIFIED CONDITIONAL TRANSFER ORDER (CTO-48) re MDL 2875 to District of New Jersey. (Attachments: #1 Email request) (jfj) |
Filing 5
INITIAL SCHEDULING ORDER: Fed.R.Civ.P. 7.1 Corporate Disclosure Statement Deadline set for 12/6/2021. Rule 26 Meeting Report due by 1/5/2022. Discovery due by 5/17/2022. Signed by JUDGE M CASEY RODGERS on 11/22/21. (jfj)
|
| ACTION REQUIRED BY DISTRICT JUDGE: Chambers of JUDGE M CASEY RODGERS notified that action is needed Re: #1 Notice of Removal, #2 Corporate Disclosure Statement/Certificate of Interested Persons, #3 Corporate Disclosure Statement/Certificate of Interested Persons, #4 Corporate Disclosure Statement/Certificate of Interested Persons. (Please see proposed ISO.) (jfj) |
| Filing 4 Corporate Disclosure Statement/Certificate of Interested Persons by Prinston Pharmaceutical, Inc., dba Solco Heathcare US, LLC identifying Corporate Parent Zhejiang Huahai Pharmaceutical Co., Ltd. for Prinston Pharmaceutical, Inc., dba Solco Heathcare US, LLC.. (GOOD, RACHEL) |
| Filing 3 Corporate Disclosure Statement/Certificate of Interested Persons by Zhejiang Huahai Pharmaceutical Co., Ltd.. (GOOD, RACHEL) |
| Filing 2 Corporate Disclosure Statement/Certificate of Interested Persons by Huahai U.S., Inc. identifying Corporate Parent Zhejiang Huahai Pharmaceutical Co., Ltd. for Huahai U.S., Inc... (GOOD, RACHEL) |
| Filing 1 NOTICE OF REMOVAL by Prinston Pharmaceutical, Inc., dba Solco Heathcare US, LLC, Huahai U.S., Inc., Zhejiang Huahai Pharmaceutical Co., Ltd. from Circuit Court Okaloosa County, case number 2021 CA 001372. ( Filing fee $ 402 receipt number AFLNDC-6550593.), filed by Prinston Pharmaceutical, Inc., dba Solco Heathcare US, LLC, Huahai U.S., Inc., Zhejiang Huahai Pharmaceutical Co., Ltd.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Civil Cover Sheet Civil Cover Sheet) (GOOD, RACHEL) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
